Since iNOS may inhibit eNOS expression during endotoxemia [55], we speculate that eNOS upregulations in these organs might be a compensatory change to inhibition of the LPS-induced iNOS expression during endotoxemia by high dose propofol. The gene discussed is NOS3; the disease is serum lipopolysaccharide activity.